The multipotent mesenchymal stem/stromal cells (MSCs), initially discovered from bone
marrow in 1976, have been identified in nearly all tissues of human body now. The …

While a large and growing body of research has demonstrated that mesenchymal
stem/stromal cells (MSCs) play a dual role in tumor growth and inhibition, studies exploring …

Mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), exist in many
tissues and are known to actively migrate to sites of tissue injury, where they participate in …

Mesenchymal stem/stromal cells (MSCs) are multipotent cells involved in numerous
physiological events, including organogenesis, the maintenance of tissue homeostasis …

Stem cell‐based therapies exhibit profound therapeutic potential for treating various human
diseases, including cancer. Among the cell types that can be used for this purpose …

This review focuses on the interaction between multipotent stromal cells (MSCs) and
carcinoma and the possible use of MSCs in cell-based anticancer therapies. MSCs are …

Mesenchymal stem cells (MSCs) are a versatile group of nonhematopoietic stem cells with
high potency of proliferation and pluripotency of differentiation. Endogenous MSCs circulate …

Mesenchymal (multipotent) stem/stromal cells (MSCs) may affect cancer progression
through a number of secreted factors triggering activation of various cell signaling pathways …

Mesenchymal stem cells (MSCs) derived from adipose tissue, bone marrow, cord blood, and
other tissues, have recently attracted much attention as potential therapeutic agents in …

Mesenchymal stem cells (MSCs) are known for being multi-potent. However, they also
possess anticancer properties, which has prompted efforts to adapt MSCs for anticancer …